News

FDA staff raises efficacy concerns for Otsuka's PTSD combination treatment
The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...
Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting
The FDA staffers on Wednesday cited efficacy issues related to a combination regimen involving brexpiprazole, an ...
Fierce Pharma1h
For Lundbeck and Otsuka's PTSD filing, FDA questions Rexulti efficacy after failed ph. 3
The FDA is raising efficacy questions over Lundbeck and Otsuka’s proposed combination of their Rexulti with Viatris’ Zoloft ...
Medscape2d
First New PTSD Drug in Two Decades On the Horizon?
An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...
Hoodline1h
Fort Worth's Modern Art Museum Hosts Free Screening of PTSD Documentary "HERE. IS. BETTER." on August 5
Fort Worth's Modern Art Museum hosts "HERE. IS. BETTER.," a PTSD-focused documentary screening. Admission is free with online ...
'Traumatic' birth left mum with PTSD and depression
A woman said she felt "robbed" of her birth experience after a "painful" and "traumatic" delivery left her with ...
MPR1d
Methylone Designated Breakthrough Therapy for PTSD
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
USF researchers develop AI that detects PTSD in children’s facial expressions
The tool can help overcome barriers to diagnosis, like cognitive development, language skills, avoidance behaviors and ...
Military members with sleep apnea far more likely to suffer PTSD, traumatic brain injuries, says U.Md. study
A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...